Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Avalon GloboCare Corp. - Common Stock
(NQ:
ALBT
)
2.650
-0.130 (-4.68%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Avalon GloboCare Corp. - Common Stock
< Previous
1
2
Next >
What's Going On With Kala Pharmaceuticals Shares Today
March 06, 2023
Kala Pharmaceutical (NASDAQ: KALA) shares skyrocketed more than 20% Monday morning on higher-than-average volume. On an average market day, Kala shares trade about 2.5 million times throughout the...
Via
Benzinga
What's Going On With Avalon GloboCare Shares Today
March 06, 2023
The overall market ticked slightly higher in pre-market trading Monday morning, but Avalon Globocare Corp (NASDAQ: ALBT) shares really took off. Avalon GloboCare is a biotech company headquartered in...
Via
Benzinga
Nasdaq Rises 50 Points; US Factory Orders Down 1.6% In January
March 06, 2023
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 50 points on Monday. Following the market opening Monday, the Dow traded up 0.24% to 33,471.14 while the NASDAQ rose...
Via
Benzinga
Avalon GloboCare Partnerships, Completed Capital Raise, And Robust IP Portfolio Expose An Attractive Value Proposition ($ALBT)
February 02, 2023
Via
AB Newswire
With Multiple Shots On Revenue-Generating Goals, Avalon GloboCare Positions For A Breakout 2023 ($ALBT)
January 31, 2023
Via
AB Newswire
Topics
Intellectual Property
Exposures
Intellectual Property
Avalon GloboCare Strengthens IP Portfolio, Earns Breakthrough Patent For QTY-Code Technology ($ALBT)
January 24, 2023
Via
AB Newswire
Topics
Intellectual Property
Exposures
Intellectual Property
Avalon GloboCare Scores Patent For Breakthrough QTY-Code Technology To Expedite Developing Better Cancer Treatments ($ALBT)
January 23, 2023
Via
AB Newswire
Topics
Intellectual Property
Exposures
Intellectual Property
Kala Pharmaceuticals, PaxMedica, Getty And Other Short Squeeze Stocks That Could Soar
January 23, 2023
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits...
Via
Benzinga
Kala Pharmaceuticals, Getty Images And This Bitcoin Stock Top Short Squeeze Leaderboard: 10 Short Squeeze Stocks To Watch
January 17, 2023
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits...
Via
Benzinga
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
December 29, 2022
Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001.
Via
Benzinga
Avalon GloboCare Stock Completes $4.0 Million Private Placement Priced At A Premium To Accelerate Closing Accretive Acquisition ($ALBT)
December 19, 2022
Via
AB Newswire
Avalon GloboCare Stock Rallies On Acquisition, Partnership, And Clinical Program Updates ($ALBT)
December 15, 2022
Via
AB Newswire
Avalon GloboCare Shares Higher; Partnerships And Planned Acquisition Fuel Investor Interest ($ALBT)
December 13, 2022
Via
AB Newswire
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
December 12, 2022
Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.